VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $6,010,000 | +27.2% | 27,056 | +13.7% | 0.03% | +23.1% |
| Q1 2015 | $4,725,000 | +68.4% | 23,787 | +21.4% | 0.03% | +62.5% |
| Q4 2014 | $2,805,000 | -47.4% | 19,600 | -51.8% | 0.02% | -51.5% |
| Q3 2014 | $5,332,000 | +76.0% | 40,642 | +69.2% | 0.03% | +83.3% |
| Q2 2014 | $3,030,000 | -54.4% | 24,023 | -52.3% | 0.02% | -55.0% |
| Q1 2014 | $6,638,000 | +55.1% | 50,352 | +38.1% | 0.04% | +42.9% |
| Q4 2013 | $4,281,000 | +120.8% | 36,464 | +96.2% | 0.03% | +115.4% |
| Q3 2013 | $1,939,000 | -44.9% | 18,581 | -54.6% | 0.01% | -45.8% |
| Q2 2013 | $3,521,000 | – | 40,905 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Analysts, LLC | 7,350 | $439,309,000 | 0.18% |
| GOLDMAN SACHS GROUP INC | 2,996,127 | $179,078,000 | 0.07% |
| MUFG Americas Holdings Corp | 52,285 | $3,125,000 | 0.06% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 22,936 | $1,367,000 | 0.05% |
| GOLDMAN SACHS GROUP INC | 419,100 | $25,050,000 | 0.01% |
| AQR Capital Management | 35,829 | $2,141,000 | 0.01% |
| HSBC HOLDINGS PLC | 33,669 | $2,009,000 | 0.01% |
| GOLDMAN SACHS GROUP INC | 147,000 | $8,786,000 | 0.00% |
| NOMURA HOLDINGS INC | 6,000 | $359,000 | 0.00% |
| Twin Tree Management, LP | 455 | $27,000 | 0.00% |